Laporan Laba Rugi (TTM)
Laporan Laba Rugi NatureWise Biotech & Medicals Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 330 | 307 | 252 | 197 | 223 | 250 | 271 | 293 | 261 | 229 | 205 | 180 | 170 | 160 | 192 | 225 | 224 | 224 | 202 | 180 |
Change (%) | -7.10 | -17.95 | -21.87 | 13.48 | 11.88 | 8.61 | 7.92 | -10.96 | -12.31 | -10.53 | -11.77 | -5.63 | -5.96 | 20.12 | 16.75 | -0.06 | -0.06 | -9.81 | -10.88 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 136 | 123 | 101 | 79 | 92 | 104 | 113 | 122 | 110 | 99 | 90 | 81 | 77 | 73 | 87 | 101 | 103 | 104 | 97 | 89 |
Change (%) | -9.15 | -17.83 | -21.69 | 15.20 | 13.19 | 9.01 | 8.27 | -9.66 | -10.69 | -8.70 | -9.53 | -5.35 | -5.66 | 19.56 | 16.36 | 1.43 | 1.41 | -7.31 | -7.89 | |
% of Revenue | 41.14 | 40.23 | 40.29 | 40.39 | 41.00 | 41.48 | 41.63 | 41.77 | 42.38 | 43.16 | 44.04 | 45.16 | 45.29 | 45.44 | 45.23 | 45.08 | 45.75 | 46.42 | 47.70 | 49.31 |
Gross Operating Profit | 194 | 183 | 150 | 117 | 132 | 146 | 158 | 171 | 150 | 130 | 114 | 99 | 93 | 87 | 105 | 123 | 122 | 120 | 106 | 91 |
Change (%) | -5.66 | -18.03 | -22.00 | 12.32 | 10.97 | 8.32 | 7.68 | -11.90 | -13.51 | -11.92 | -13.53 | -5.85 | -6.22 | 20.58 | 17.07 | -1.27 | -1.29 | -11.98 | -13.61 | |
% of Revenue | 58.86 | 59.77 | 59.71 | 59.61 | 59.00 | 58.52 | 58.37 | 58.23 | 57.62 | 56.84 | 55.96 | 54.84 | 54.71 | 54.56 | 54.77 | 54.92 | 54.25 | 53.58 | 52.30 | 50.69 |
SG&A | 61 | 57 | 53 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 54 | 53 | 54 | 54 | 56 | 59 | 59 | 60 | 59 | 57 |
Change (%) | -5.83 | -8.03 | -8.73 | 1.65 | 1.62 | 1.89 | 1.86 | 2.39 | 2.33 | -0.68 | -0.69 | 0.54 | 0.54 | 4.42 | 4.23 | 1.23 | 1.22 | -2.50 | -2.57 | |
% of Revenue | 18.44 | 18.70 | 20.95 | 24.48 | 21.93 | 19.92 | 18.68 | 17.63 | 20.28 | 23.67 | 26.27 | 29.57 | 31.50 | 33.68 | 29.28 | 26.14 | 26.48 | 26.82 | 28.99 | 31.69 |
R&D | 69 | 68 | 72 | 76 | 73 | 69 | 65 | 61 | 55 | 49 | 42 | 34 | 32 | 30 | 43 | 57 | 64 | 72 | 75 | 78 |
Change (%) | -0.80 | 5.94 | 5.60 | -4.44 | -4.65 | -6.36 | -6.79 | -9.19 | -10.12 | -15.46 | -18.29 | -6.11 | -6.51 | 44.43 | 30.76 | 13.58 | 11.96 | 4.35 | 4.17 | |
% of Revenue | 20.79 | 22.20 | 28.66 | 38.74 | 32.62 | 27.80 | 23.97 | 20.71 | 21.12 | 21.65 | 20.45 | 18.94 | 18.85 | 18.74 | 22.53 | 25.23 | 28.68 | 32.13 | 37.17 | 43.45 |
OpEx | 266 | 249 | 226 | 204 | 213 | 223 | 229 | 235 | 218 | 202 | 186 | 169 | 163 | 157 | 187 | 217 | 226 | 236 | 230 | 224 |
Change (%) | -6.23 | -9.07 | -9.97 | 4.65 | 4.45 | 2.63 | 2.56 | -6.89 | -7.40 | -8.21 | -8.94 | -3.65 | -3.78 | 19.11 | 16.05 | 4.55 | 4.35 | -2.53 | -2.60 | |
% of Revenue | 80.38 | 81.13 | 89.91 | 103.61 | 95.55 | 89.20 | 84.29 | 80.11 | 83.78 | 88.47 | 90.77 | 93.67 | 95.64 | 97.86 | 97.04 | 96.45 | 100.90 | 105.36 | 113.86 | 124.45 |
Operating Income | 65 | 58 | 25 | -7 | 10 | 27 | 43 | 58 | 42 | 26 | 19 | 11 | 7 | 3 | 6 | 8 | -2 | -12 | -28 | -44 |
Change (%) | -10.64 | -56.13 | -127.92 | -240.09 | 171.38 | 57.95 | 36.69 | -27.38 | -37.71 | -28.33 | -39.52 | -34.96 | -53.76 | 65.93 | 39.73 | -125.46 | 492.80 | 133.42 | 57.16 | |
% of Revenue | 19.62 | 18.87 | 10.09 | -3.61 | 4.45 | 10.80 | 15.71 | 19.89 | 16.22 | 11.53 | 9.23 | 6.33 | 4.36 | 2.14 | 2.96 | 3.55 | -0.90 | -5.36 | -13.86 | -24.45 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |
Change (%) | -15.52 | -18.37 | -10.00 | -11.11 | 10.94 | 9.86 | 1.28 | 1.27 | -0.00 | -0.00 | 15.00 | 13.04 | 32.69 | 24.64 | 7.56 | 7.03 | -10.10 | -11.24 | ||
% of Revenue | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | |
Net Income | 70 | 65 | 33 | -0 | 15 | 31 | 47 | 63 | 46 | 30 | 23 | 16 | 13 | 10 | 13 | 16 | 8 | 1 | -18 | -37 |
Change (%) | -7.35 | -50.21 | -100.82 | -5,797.76 | 101.76 | 51.49 | 33.99 | -25.99 | -35.12 | -23.49 | -30.70 | -18.22 | -22.27 | 27.87 | 21.79 | -47.15 | -89.23 | -2,112.82 | 104.97 | |
% of Revenue | 21.34 | 21.28 | 12.91 | -0.14 | 6.84 | 12.33 | 17.20 | 21.36 | 17.75 | 13.13 | 11.23 | 8.82 | 7.65 | 6.32 | 6.73 | 7.02 | 3.71 | 0.40 | -8.92 | -20.53 |
Source: Capital IQ